🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
🔬 Top Biotech News Here are the key developments in biotechnology this week: 1️⃣ StockWatch: After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results 2️⃣ GlycoNet/Alberta Innovates – Driving health research to market for Alberta’s future 3️⃣ AI is changing how we quantify pain 4️⃣ BIO on the American Road: Biotech innovation and job growth in Illinois 5️⃣ The race to make the perfect baby is creating an ethical mess 6️⃣ Sick Cells: Elevating the patient voice 7️⃣ Enhancing Sp...
BioTech Weekly
🔬 This Week’s Top Biotech News Here are the biggest stories shaping the world of biotechnology this week 👇 Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiopharma Embraces Synthetic BiologySanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPDStockWatch: Intellia Shares Sink as Clinical Hold Follows Safety SetbackBird Flu’s Human Risk Spurs Phage Therapy ResearchThis Retina Implant Lets People with Vision Loss Do a Crosswor...
